X4 Pharmaceuticals Inc
XFOR
$2.71-4.08%
Delayed · as of Oct 13, 2026, 1:01 PM ET
Mkt cap
$381.99M
EV/Sales
36.9
P/E ratio
N/A
FY2025 Revenue
$6.50M
EPS (H1 2026)
$-0.29
Gross Margin (FY2025)
11.43%
Profit Margin (FY2025)
-1218.45%
Beta
N/A
Div yield
N/A
Sector
Healthcare
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Latest reported XFOR revenue for 2025-12-31 was $6.5M. Net income was -$79.2M. Revenue was up 150.0% from 2024-12-31 to 2025-12-31. XFOR currently screens at market cap $382.0M.
Use this XFOR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full XFOR income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company in the Healthcare sector.
Latest cached X4 Pharmaceuticals Inc (XFOR) revenue for Dec 31, 2025 was $6.5M. Net income was -$79.2M. Statements: https://lician.com/financials/xfor
X4 Pharmaceuticals Inc (XFOR) market capitalization is $382.0M on the latest cached snapshot.
X4 Pharmaceuticals Inc (XFOR) cached previous close $2.82; day range $2.71 – $2.81; volume 141,977. Session quote: https://lician.com/quote/xfor
X4 Pharmaceuticals Inc (XFOR) latest cached earnings event is "XFOR earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached XFOR filing is 8-K · Oct 8, 2026. Filings: https://lician.com/sec/xfor